Skip to main content
OpenTrials
Completed

NCT Number: NCT04447534

Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Tanta university hospital, Assuit University, Ainshams University

Tanta, Egypt

About this study

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroquine effect.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with positive COVID-19.

Exclusion criteria

  • Contraindications or hypersensitivity to chloroquine.

Treatment and study plan

Chloroquine or Hydroxychloroquine

Drug

Chloroquine or hydroxychloroquine

Other names: alexoquine, chloroquine, hydroquine

Zinc

Drug

Zinc tablets

Primary outcomes

  1. Number of patients with improvement or mortality

    Time frame: 2 weeks

    The number of patients with improvement or mortality.

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine in Treatment of COVID-19?

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 25, 2020
Registry last updated
Apr 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.